ng28ÄϹ¬

ÌõÄ¿µÄ

ng28ÄϹ¬ÓÃÓÚÖÎÁÆÅÁ½ðÉ­²¡µÄEQUFINA?Ƭ¼ÁÔÚº«¹ú»ñµÃÅú×¼

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬Ê×ϯִÐй٣ºÄÚÌÙÇç·ò £¬ÒÔϼò³Æ¡°ng28ÄϹ¬¡±£©½üÈÕÐû²¼ £¬ng28ÄϹ¬ÔÚº«×Ó¹«Ë¾ng28ÄϹ¬Öêʽ£¨º«¹ú£©»áÉçÒÑ»ñµÃº«¹ú¼à¹Ü»ú¹¹£¨Ê³Æ·ºÍÒ©Æ·Äþ¾²²¿£©ËùÊÚÓèµÄ¹ØÓÚÅÁ½ðÉ­²¡ÖÎÁÆÒ©ÎïEqufina?£¨¼×»ÇËáɳ·Òõ£°· £¬ÒÔϼò³Æ¡°É³·Òõ£°·¡±£©µÄÉÏÊÐÐí¿É £¬¸ÃÒ©×÷Ϊº¬×óÐý¶à°ÍÒ©ÎïµÄ¼ÓÓÃÖÎÁÆ £¬ÓÃÓÚÖÎÁÆ°é¼ÁÄ©Ô˶¯²¨¶¯µÄÔ­·¢ÐÔÅÁ½ðÉ­²¡»¼Õß¡£2019Äê7ÔÂÒÑÓÚº«¹úÌύɳ·Òõ£°·µÄÉÏÊÐÐí¿ÉÉêÇë £¬Í¨¹ýÅú×¼¸ÃÉêÇë £¬º«¹ú³ÉΪ³ýÈÕ±¾Ö®ÍâÑÇÖÞµÚÒ»¸öÊÚÓèɳ·Òõ£°·ÉÏÊÐÐí¿ÉµÄ¹ú¼Ò¡£

ng28ÄϹ¬ÔÚÃÀ¹úÉÏÊÐÐÂÒ©DAYVIGO?£¨LEMBOREXANT£©CIVÓÃÓÚÖÎÁƳÉÄêÈ˵ÄʧÃß

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬CEO£ºÄÚÌÙÇç·ò £¬¡°ng28ÄϹ¬¡±£©½üÈÕÐû²¼ £¬ÆäÃÀ¹ú×Ó¹«Ë¾Eisai Inc.ÒÑÓÚÃÀ¹úÉÏÊÐÆäÄÚ²¿Ñз¢µÄʳÓûËØÊÜÌåÞ׿¹¼ÁDAYVIGO?£¨LEMBOREXANT£©CIVÓÃÓÚÖÎÁƳÉÄêÈ˵ÄʧÃß £¬¸Ã²¡¾ßÌåÌåÏÖΪÈë˯ºÍ/»òά³Ö˯ÃßÕÏ°­¡£

°¬²®Î¬£¨AbbVie£©ºÍng28ÄϹ¬£¨Eisai£©Ðû²¼¶ÔHUMIRA?£¨Ò»ÖÖÈ«ÈËÔ´¿¹TNF¦Áµ¥¿Ë¡¿¹Ì壩µÄÏúÊÛÐí¿É½øÐв¿·Ö¸ü¸Ä £¬Éæ¼°»¯Å§ÐÔº¹ÏÙÑ×ÊÊÓ¦Ö¢µÄ¼ÁÁ¿ºÍ¸øÒ©

°¬²®Î¬GK£¨×ܲ¿£º¶«¾©¶¼¸ÛÇø£»×ܲãºJames Feliciano £¬ÒÔϳơ°°¬²®Î¬¡±£©ºÍng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾©£»Ê×ϯִÐй٣ºÄÚÌÙÇç·ò £¬ÒÔϳơ°ng28ÄϹ¬¡±£©½ñÌìÐû²¼ÐÞÃÀÀÖ?È«ÈËÔ´¿¹TNF¦Áµ¥¿Ë¡¿¹ÌåµÄ²¿·Ö±ä»»ÉÏÊÐÐí¿É £¬¹ØÓÚÌرð¼ÁÁ¿ºÍ¸øÒ© £¬ÌرðÊÇÔÚÖÎÁƵÄÇ°4Öܺó £¬Ã¿¸ôÒ»ÖÜ£¨Q2W£©Ìí¼Ó80mg £¬¿É×÷ΪÖÎÁÆ»¯Å§ÐÔº¹ÏÙÑ×£¨ÒÔϼò³Æ¡°?HS¡±£©»¼ÕßÖÎÁƼƻ®µÄÒ»ÖÖÑ¡Ôñ¡£

EISAI½«ÔÚASCOÄê¶È¼¯»áÉÏչʾÖ×Áö¹ÜÏߺͲúÆ·Êý¾Ý

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬Ê×ϯִÐй٣ºÄÚÌÙÇç·ò £¬¡°ng28ÄϹ¬¡±£©Ðû²¼ £¬¼×»ÇËáÂØ·¥ÌæÄᣨ¿Ú·þ¶à°ÐµãÀÒ°±ËἤøÊÜÌåÒÖÖƼÁ £¬²úÆ·Ãû³Æ£ºÀÖÎÀÂê? £¬ÒÔϼò³Æ¡°ÂØ·¥ÌæÄᡱ£©ºÍ¼×»ÇËá°¬Á¢²¼ÁÖ£¨Èíº£ÃàËØÀà΢¹Ü¶¯Á¦Ñ§ÒÖÖƼÁ £¬²úÆ·Ãû³Æ£ºº£ÀÖÎÀ? £¬¡°°¬Á¢²¼ÁÖ¡±£©µÄһϵÁÐÕªÒª½«ÔÚ2020Äê5ÔÂ29ÈÕÖÁ31ÈÕÃÀ¹úÁÙ´²Ö×Áöѧ»á£¨ASCO20ÐéÄâ¿Æѧ¼Æ»®£©ÉÏÐû²¼¡£

ng28ÄϹ¬ÔÚ¡¶Institutional Investor£¨»ú¹¹Í¶×ÊÕߣ©¡·ÔÓÖ¾Ðû²¼µÄ×î¼ÑIRÆóÒµÅÅÃûÖÐÃûÁеÚÒ» £¬²¢ÈÙ»ñ¡°×îÊÜ×ð³çÆóÒµ¡±ÈÙÓþ

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬CEO£ºÄÚÌÙÇç·ò£©½üÈÕÐû²¼ £¬ÆäÔÚÃÀ¹ú½ðÈÚÐÅÏ¢ÔÓÖ¾¡¶Institutional Investor£¨»ú¹¹Í¶×ÊÕߣ©¡·Ðû²¼µÄ¡°È«ÈÕ±¾Ö´ÐÐÍŶӡ±?ÉúÎï¼¼ÊõºÍÖÆÒ©ÁìÓòÆóÒµÖÐÅÅÃûµÚÒ» £¬²¢ÈÙ»ñ¡°×î¼ÑCEO¡±¡¢¡°×î¼ÑCFO¡±ºÍ¡°×îÊÜ×ð³çÆóÒµ¡±ÈÙÓþ¡£

ng28ÄϹ¬ÓëÉú»¯Ñ§¹¤ÒµÇ©ÊðÖÎÁƹÇÊàŦÑ×SI-613ÔÚÖйúÁªºÏ¿ª·¢ºÍÏúÊÛÏàÖúЭÒé

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬Ê×ϯִÐй٣ºƒÈÌÙÇç·ò £¬¡°ng28ÄϹ¬¡±£©ºÍÉú»¯Ñ§¹¤ÒµÖêʽ»áÉ磨×ܲ¿£º¶«¾© £¬×ܲãºË®¹È½¨ £¬¡°Éú»¯Ñ§¹¤Òµ¡±£©Ðû²¼ £¬Ë«·½¾ÍSI-613£¨Ë«ÂÈ·ÒËá¹²éî͸Ã÷ÖÊËáÄÆ£©ÔÚÖйúÁªºÏ¿ª·¢ºÍÏúÊ۸濢ÏàÖúЭÒé £¬¸Ã²úÆ·ÊÇÓÉÉú»¯Ñ§¹¤ÒµÑз¢µÄÒ»ÖÖ¹ÇÊàŦÑ×ÖÎÁƼÁ¡£

µÚÁù½ìng28ÄϹ¬ÖйúGIVEÏû»¯¼²²¡ÕïÁÆÂÛ̳£¨ÔÚÏ߰棩Àֳɾٰì

2020Äê3ÔÂ20ÈÕ¡¢3ÔÂ27ÈÕ £¬ÓÉng28ÄϹ¬£¨¼ò³Æ¡°ng28ÄϹ¬ÖйúÒ©Òµ¡±£©Ö÷°ìµÄµÚÁù½ìng28ÄϹ¬ÖйúGIVE£¨Gastrointestinal &Liver Disease Treatment Forum £¬ÒÔϼò³Æ¡°GIVE¡±£©Ïû»¯¼²²¡ÕïÁÆÂÛ̳£¨ÔÚÏ߰棩Á½³¡¾ùÒÑÀÖ³ÉÂäÄ»¡£ÒßÇéÆÚ¼ä £¬ÎªÖÆÖ¹ÈËÔ±¾Û¼¯ £¬´Ë´ÎÂÛ̳½ÓÄÉÁËÁ¢ÒìµÄÏßÉϼ¯»áģʽ

ng28ÄϹ¬ÔÚÈÕ±¾Ìá½»¹ØÓÚƤ·ôTϸ°ûÁÜ°ÍÁöºÍÍâÖÜTϸ°ûÁÜ°ÍÁöµÄ¿¹°©Ò©DENILEUKIN DIFTITOX£¨»ùÒòÖØ×éÌ壩µÄÉÏÊÐÐí¿ÉÉêÇë

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬CEO£ºÄÚÌÙÇç·ò £¬¡°ng28ÄϹ¬¡±£©½üÈÕÐû²¼ £¬ÆäÒÑÔÚÈÕ±¾Ìá½»DENILEUKIN DIFTITOX£¨»ùÒòÖØ×飩£¨Í¨ÓÃÃû £¬¿ª·¢´úÂ룺E7777£©µÄÉÏÊÐÊÚȨÉêÇë £¬ÓÃÓÚÖÎÁƸ´·¢ÐÔ»òÄÑÖÎÐÔƤ·ôTϸ°ûÁÜ°ÍÁö£¨CTCL£©ºÍÍâÖÜTϸ°ûÁÜ°ÍÁö£¨PTCL£©¡£

“2020ng28ÄϹ¬Éñ¾­¿Æѧá¯ÁëÂÛ̳”£¨ÔÚÏ߰棩˳ÀûÕÙ¿ª

2020Äê3ÔÂ22ÈÕ £¬ÓÉng28ÄϹ¬£¨¼ò³Æ”ng28ÄϹ¬ÖйúÒ©Òµ”£©ÇãÁ¦´òÔìµÄ”ng28ÄϹ¬Éñ¾­¿Æѧá¯ÁëÂÛ̳”£¨Empowering Neurology¡¯s Future £¬¼ò³Æ: ENF£©?˳ÀûÕÙ¿ª¡£ÒßÇéÆÚ¼ä £¬ÎªÖÆÖ¹ÈËÔ±¾Û¼¯ £¬´Ë´ÎÂÛ̳½ÓÄÉÁËÁ¢ÒìµÄÏßÉϼ¯»áģʽ £¬2020ng28ÄϹ¬ÖйúÒ©ÒµENFÈ«ÐÂÔÚÏßѧÊõ¼¾ÖØ°õ¿ªÆô £¬´Ó3ÔÂ22ÈÕÖÁ4ÔÂ28ÈÕ £¬Ã¿ÖÜÒ»ÆÚ £¬¹²¼ÆÆßÆÚ¡£

ng28ÄϹ¬Öйú¡°ÎÀ¡±ÄãÊØ»¤ £¬¹²¿Ëʱ¼è

Ãæ¶ÔÐÂÐ͹Ú×´²¡¶¾Ñ¬È¾µÄ·ÎÑ×ÒßÇé £¬´ó×ÚÓÐÕý³£¾ÍÕïÐèÇóµÄ»¼ÕßÎÞ·¨µ½Ò½Ôº¾ÍÒ½ £¬ËûÃǵļ²²¡ÎÞ·¨»ñµÃÁ¼ºÃµÄÕïÁÆ £¬ÑÏÖؽµµÍÁ˲¡È˵ÄÉú»îÖÊÁ¿¡£ng28ÄϹ¬£¨Öйú£©Í¶×ÊÓÐÏÞ¹«Ë¾ÕýÁªºÏÉç»á¸÷½çһͬ¿¹»÷ÒßÇé £¬¡°ÎÀ¡±ÄãÊØ»¤ £¬¹²¿Ëʱ¼è¡£

ÍøÕ¾µØͼ